Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Cluster Randomised Trial of Interferon Versus Standard of Care in the Reduction of Transmission of SARS-Cov-2. The Containing Coronavirus Disease 19 Trial (ConCorD-19)

NCT04552379 is registered in ClinicalTrials.gov with Pontificia Universidad Catolica de Chile as lead sponsor.

NCT NCT04552379
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04552379 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Cluster Randomised Trial of Interferon Versus Standard of Care in the Reduction of Transmission of SARS-Cov-2. The Containing Coronavirus Disease 19 Trial (ConCorD-19)
Lead sponsor
Pontificia Universidad Catolica de Chile
Phase
Phase 3
Overall status
Completed
Start date
December 1, 2020
Completion date
June 30, 2021
Enrollment
1,173 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, interferon, sars-cov infection